New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer
Maiko Niki, Takashi Yokoi, Takayasu Kurata, Shosaku Nomura First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka, Japan Background: Several biomarkers have emerged as potential prognostic and predictive markers for non-small-cell lung cancer (NS...
Guardado en:
Autores principales: | Niki M, Yokoi T, Kurata T, Nomura S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a6bca5b1f02e45a4a34f41ea17061e64 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bevacizumab-induced esophageal pleural fistula during maintenance therapy without radiation in lung cancer
por: Ting Wang, et al.
Publicado: (2021) -
Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
por: Maja Šutić, et al.
Publicado: (2021) -
Disulfiram-loaded porous PLGA microparticle for inhibiting the proliferation and migration of non-small-cell lung cancer
por: Wang C, et al.
Publicado: (2017) -
Pancreatic Cancer and Platelets Crosstalk: A Potential Biomarker and Target
por: Shaoshan Mai, et al.
Publicado: (2021) -
NFAT as a Biomarker and Therapeutic Target in Non–Small Cell Lung Cancer–Related Brain Metastasis
por: Lu Peng, et al.
Publicado: (2021)